Siemens Healthineers
Siemens also had a new product, the Artis pheno. The vendor received FDA 510k approval just a few days before the ACC so it did not have a significant booth release planned. The Artis pheno represents Siemens’ next-generation solution for the Artis zeego. This is a unique, robotic gantry C-arm that is floor-mounted but has flexibility to be mounted away from the head of the table for better access in the hybrid OR setting, pediatric, and other applications where access to the patient at the top of the table is an important factor.

This will continue to be a premium solution for Siemens targeting the hybrid OR. A new special coating and gantry are designed to reduce the chance of contamination in the OR. All cables are now enclosed in the gantry arm, and the table now offers a much higher table weight capacity. This continues Siemens’ focus on high-end specialty application solutions that address a broad range of applications: cardiac, cardiovascular, vascular, oncology, electrophysiology, and neurology.
Other significant a technology highlighted at the meeting

Siemens Healthineers
Cardiovascular ecosystem – TeamPlay and a comprehensive dashboard to view all aspects of data being acquired through Siemens’ technology as well as other vendors’ technology. The vendor envisions third-party applications being developed that could be used with the TeamPlay solution to expand data analytics and data evaluation capabilities. This would assist the physicians and clinicians with efficiencies and diagnostic determinations and metrics to more accurately and comprehensively impact positive workflow and patient outcomes. Siemens introduced a new advance to its MR, Compressed Sensing, which is designed to provide cardiac MR in a fraction of the time previously required. It will continue to move noninvasive cardiac MR toward a more mainstream solution.

Philips
Significant clinical studies, DEFINE-FLAIR and iFR-SWEDEHART, provided findings that suggest instantaneous Frequency Flow (iFR) is shown to be non-inferior to Frequency Flow Reserve (FFR) measurements. This is a significant factor because FFR requires longer measurement times and the use of Adenosine (vaso-dilator), which increases cost and has some patient-related side effects. This specialized measurement technique is exclusive to Volcano, a division of Philips. However, the technology is available and can be used with any imaging vendor’s technology.

Meanwhile, on the show floor...
This year’s ACC Scientific Session and Expo was held in Washington, D.C., and included more than 300 sessions organized into 10 specialized learning pathways. These learning pathways included the diagnosis and treatment of various cardiovascular diseases, as well as guidelines to improve patient outcomes. The expo center housed more than 275 vendors, which included many imaging vendors and device manufacturers showcasing the latest advancements and solutions in cardiovascular technology.

Back to HCB News

Cardiology Homepage